Asserter profile
Barclays Bank PLC, as Collateral Agent
operating company0 patents now12 ever0 cases filed during tenure9 connections
Also seen as: BARCLAYS BANK PLC, as collateral agent · Barclays Bank PLC, as collateral agent
Two-hop network
Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.
flowchart LR
Nbarclays_bank_as_collateral_agent["Barclays Bank PLC, as Collateral Agent"]
Nbausch_health_poland_sp_z_o_o_f_k_a_valeant_pharma_poland_an["Bausch Health Poland sp. z o.o. (f/k/a…"]
Nteradyne_litepoint["TERADYNE, INC.; LITEPOINT CORPORATION"]
Nteradyne_litepoint_eagle_test_systems_nextest_systems_genrad["TERADYNE, INC.; LITEPOINT CORPORATION;…"]
Njazz_pharmaceuticals_jazz_pharmaceuticals_jazz_pharmaceutica["Jazz Pharmaceuticals, Inc.; Jazz Pharma…"]
Njazz_pharmaceuticals_jazz_pharma_jazz_pharma_iii["Jazz Pharmaceuticals, Inc.; Jazz Pharma…"]
Neusa_pharma_usa_jazz_pharmaceuticals_jazz_pharmaceuticals["EUSA Pharma (USA), Inc.; Jazz Pharmaceu…"]
Njazz_pharmaceuticals_jazz_pharmaceuticals_eusa_pharma_usa["Jazz Pharmaceuticals International Limi…"]
Njazz_pharmaceuticals_jpi_commercial_orphan_medical_entities_["Jazz Pharmaceuticals, Inc. / JPI Commer…"]
Njazz_pharmaceuticals_eusa_pharma_usa_jazz_pharmaceuticals["Jazz Pharmaceuticals International Limi…"]
Nbarclays_bank["Barclays Bank PLC"]
Nbarclays_bank_as_collateral_agent -->|"2025 · Release · 6815542"| Nbausch_health_poland_sp_z_o_o_f_k_a_valeant_pharma_poland_an
Nteradyne_litepoint -->|"2015 · Security Agreement · 8279603"| Nbarclays_bank_as_collateral_agent
Nbarclays_bank_as_collateral_agent -->|"2019 · Release · 8279603"| Nteradyne_litepoint_eagle_test_systems_nextest_systems_genrad
Njazz_pharmaceuticals_jazz_pharmaceuticals_jazz_pharmaceutica -->|"2012 · Security Agreement · 8589182"| Nbarclays_bank_as_collateral_agent
Nbarclays_bank_as_collateral_agent -->|"2015 · Release · 8589182"| Njazz_pharmaceuticals_jazz_pharma_jazz_pharma_iii
Neusa_pharma_usa_jazz_pharmaceuticals_jazz_pharmaceuticals -->|"2012 · Security Interest · 7895059"| Nbarclays_bank_as_collateral_agent
Neusa_pharma_usa_jazz_pharmaceuticals_jazz_pharmaceuticals -->|"2012 · Security Interest · 7765107"| Nbarclays_bank_as_collateral_agent
Nbarclays_bank_as_collateral_agent -->|"2015 · Release · 7765107"| Neusa_pharma_usa_jazz_pharmaceuticals_jazz_pharmaceuticals
Neusa_pharma_usa_jazz_pharmaceuticals_jazz_pharmaceuticals -->|"2012 · Security Interest · 7765106"| Nbarclays_bank_as_collateral_agent
Neusa_pharma_usa_jazz_pharmaceuticals_jazz_pharmaceuticals -->|"2012 · Security Interest · 7262219"| Nbarclays_bank_as_collateral_agent
Nbarclays_bank_as_collateral_agent -->|"2015 · Release by Secured Party · 7262219"| Njazz_pharmaceuticals_jazz_pharmaceuticals_eusa_pharma_usa
Njazz_pharmaceuticals_jpi_commercial_orphan_medical_entities_ -->|"2012 · Security Interest · 6780889"| Nbarclays_bank_as_collateral_agent
Nbarclays_bank_as_collateral_agent -->|"2015 · Release · 6780889"| Neusa_pharma_usa_jazz_pharmaceuticals_jazz_pharmaceuticals
Neusa_pharma_usa_jazz_pharmaceuticals_jazz_pharmaceuticals -->|"2012 · Security Interest · 8324275"| Nbarclays_bank_as_collateral_agent
Nbarclays_bank_as_collateral_agent -->|"2015 · Release by Secured Party · 8324275"| Njazz_pharmaceuticals_eusa_pharma_usa_jazz_pharmaceuticals
Neusa_pharma_usa_jazz_pharmaceuticals_jazz_pharmaceuticals -->|"2012 · Security Agreement · 8263650"| Nbarclays_bank_as_collateral_agent
Nbarclays_bank_as_collateral_agent -->|"2015 · Release · 8263650"| Njazz_pharmaceuticals_jazz_pharmaceuticals_eusa_pharma_usa
Neusa_pharma_usa_jazz_pharmaceuticals_jazz_pharmaceuticals -->|"2012 · Security Interest · 7851506"| Nbarclays_bank_as_collateral_agent
Nbarclays_bank_as_collateral_agent -->|"2015 · Release by Secured Party · 7851506"| Neusa_pharma_usa_jazz_pharmaceuticals_jazz_pharmaceuticals
Neusa_pharma_usa_jazz_pharmaceuticals_jazz_pharmaceuticals -->|"2012 · Security Agreement · 6472431"| Nbarclays_bank_as_collateral_agent
Nbarclays_bank_as_collateral_agent -->|"2015 · Release · 6472431"| Neusa_pharma_usa_jazz_pharmaceuticals_jazz_pharmaceuticals
Neusa_pharma_usa_jazz_pharmaceuticals_jazz_pharmaceuticals -->|"2012 · Security Agreement · 8461203"| Nbarclays_bank_as_collateral_agent
Nbarclays_bank_as_collateral_agent -->|"2015 · Release · 8461203"| Njazz_pharmaceuticals_jazz_pharmaceuticals_eusa_pharma_usa
Neusa_pharma_usa_jazz_pharmaceuticals_jazz_pharmaceuticals -->|"2012 · Security Interest · 7668730"| Nbarclays_bank
Nbarclays_bank -->|"2015 · Release by Secured Party · 7895059"| Neusa_pharma_usa_jazz_pharmaceuticals_jazz_pharmaceuticals
Nbarclays_bank -->|"2015 · Release by Secured Party · 7765106"| Njazz_pharmaceuticals_jazz_pharmaceuticals_eusa_pharma_usa
classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
class Nbarclays_bank_as_collateral_agent focal
class Nbausch_health_poland_sp_z_o_o_f_k_a_valeant_pharma_poland_an operating
class Nteradyne_litepoint operating
class Nteradyne_litepoint_eagle_test_systems_nextest_systems_genrad operating
class Njazz_pharmaceuticals_jazz_pharmaceuticals_jazz_pharmaceutica operating
class Njazz_pharmaceuticals_jazz_pharma_jazz_pharma_iii operating
class Neusa_pharma_usa_jazz_pharmaceuticals_jazz_pharmaceuticals operating
class Njazz_pharmaceuticals_jazz_pharmaceuticals_eusa_pharma_usa operating
class Njazz_pharmaceuticals_eusa_pharma_usa_jazz_pharmaceuticals operating
class Nbarclays_bank operating
Patents previously held (12)
- US 85891822012-06-12 → 2015-06-18
- US 78950592012-08-06 → 2015-06-19
- US 77651072012-08-06 → 2015-06-19
- US 77651062012-08-06 → 2015-06-19
- US 72622192012-08-06 → 2015-06-19
- US 67808892012-08-06 → 2015-06-19
- US 83242752012-08-06 → 2015-06-19
- US 82636502012-08-06 → 2015-06-19
- US 78515062012-08-06 → 2015-06-19
- US 64724312012-08-06 → 2015-07-09
- US 84612032012-08-06 → 2015-06-19
- US 82796032015-04-27 → 2019-06-28
Connected entities (9)
- EUSA Pharma (USA), Inc.; Jazz Pharmaceuticals International Limited; Jazz Pharmaceuticals, Inc.operating company10 patents
- Jazz Pharmaceuticals International Limited; Jazz Pharmaceuticals, Inc.; EUSA Pharma (USA), Inc.operating company3 patents
- Bausch Health Poland sp. z o.o. (f/k/a Valeant Pharma Poland) and ~30 affiliated Bausch/Salix/OraPharma/Solta entitiesoperating company1 patent
- TERADYNE, INC.; LITEPOINT CORPORATIONoperating company1 patent
- TERADYNE, INC.; LITEPOINT CORPORATION; EAGLE TEST SYSTEMS, INC.; NEXTEST SYSTEMS CORPORATION; GENRAD, LLC; ENERGID TECHNOLOGIES CORPORATIONoperating company1 patent
- Jazz Pharmaceuticals, Inc.; Jazz Pharmaceuticals International Limited; Jazz Pharmaceuticals International III Limitedoperating company1 patent
- Jazz Pharmaceuticals, Inc.; Jazz Pharma International Limited; Jazz Pharma International III Limitedoperating company1 patent
- Jazz Pharmaceuticals, Inc. / JPI Commercial, LLC / Orphan Medical entities and affiliatesunclassified1 patent
- Jazz Pharmaceuticals International Limited; EUSA Pharma (USA), Inc.; Jazz Pharmaceuticals, Inc.operating company1 patent